Author:
Grist Emily,de Bono Johann S.,Attard Gerhardt
Funder
Amgen
Astellas
AstraZeneca
Boehringer Ingelheim
Bristol-Myers Squibb
Dendreon
Enzon
Exelixis
Genentech
GlaxoSmithKline
Medivation
Merck
Novartis
Pfizer
Roche
Sanofi-Aventis
Supergen
Takeda
Janssen
Millennium Pharmaceuticals
Ipsen
Subject
Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference71 articles.
1. Cancer Research UK, Cancer Risk. 2012; Available from: http://www.cancerresearchuk.org/cancer-info/cancerstats/incidence/risk
2. Studies on prostate cancer. The effect of castration, or estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate;Huggins;Cancer Res.,1941
3. Can combined androgen blockade provide long-term control or possible cure of localized prostate cancer?;Labrie;Urology,2002
4. The current state of hormonal therapy for prostate cancer;Hellerstedt;CA Cancer J. Clin.,2002
5. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N. Engl. J. Med.,2011